Export citation

Show simple item record

dc.contributor.authorTakashi Shimizu*
dc.contributor.authorRan Nir-Paz*
dc.contributor.authorTakeshi Saraya*
dc.contributor.authorAnnemarie Van Rossum*
dc.contributor.authorCecile Bebear*
dc.date.accessioned2021-02-11T20:26:36Z
dc.date.available2021-02-11T20:26:36Z
dc.date.issued2017*
dc.date.submitted2018-02-27 16:16:45*
dc.identifier25662*
dc.identifier.issn16648714*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/54175
dc.description.abstractMycoplasma pneumoniae (Mp) is a major human pathogen that causes both upper and lower respiratory infections, and is one of the leading causes of community acquired pneumonia (CAP), accounting for 11–15% of CAP throughout the world. Additionally it is known to induce an inflammatory process which depends on several mechanisms such as virulence of Mp (lipoproteins, community acquired respiratory distress syndrome (CARDS) toxin, oxidative products) and host defenses (cellular immunity and humoral immunity). Although it is a common pathogen, the pathogenesis for Mp infections is not yet fully understood. From the clinical point of view, since the pioneer studies in the 1960s and 1970s on the clinical presentation of Mp associated disease, the diagnostics approaches have changed dramatically leading to a better understanding of the clinical presentation and new issues have emerged - such as antibiotics resistance. The purpose of this Frontiers ebook is to thoroughly review and discuss the clinical presentation in view of the improved diagnostics, microbiological and immunological analysis of Mp infections, with focus on the history of Mp, clinical features of disease, bacterial structure of Mp and mechanism of gliding, clinical and laboratory diagnostics, the role of lipoproteins and Toll-like receptor, CARDS toxin, subtyping of Mp isolates and genome analysis, macrolide resistance and treatment.*
dc.languageEnglish*
dc.relation.ispartofseriesFrontiers Research Topics*
dc.subjectR5-920*
dc.subjectQR1-502*
dc.subjectQ1-390*
dc.subject.otherpathogenesis*
dc.subject.otherepidemiology*
dc.subject.othertreatment*
dc.subject.otherclinical presentation antimicrobial resistance*
dc.subject.otherMycoplasma pneumoniae*
dc.subject.otheroutcome*
dc.titleMycoplasma pneumoniae Clinical Manifestations, Microbiology, and Immunology*
dc.typebook
oapen.identifier.doi10.3389/978-2-88945-362-7*
oapen.relation.isPublishedBybf5ce210-e72e-4860-ba9b-c305640ff3ae*
virtual.oapen_relation_isPublishedBy.publisher_nameFrontiers Media SA
virtual.oapen_relation_isPublishedBy.publisher_websitewww.frontiersin.org
oapen.relation.isbn9782889453627*
oapen.pages175*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/